Database

Startups

Main Industry
Biotechnology
Main Product/Service
Develop innovative therapies for cancer and immunological diseases.
Founded Year
2017
Unified Business No.
52625245
Status
Active
Number of Employees
0
Total Paid-in Capital
621,180,000 (NT$)
Location of Company
Taiwan , Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
About the Company
Elixiron Immunotherapeutics employs advances in translational medicine to identify targets from clinical observations, and various drug modalities including biologics from phage display and single human B cell cloning platforms, to develop innovative therapies for cancer and immunological diseases.



More ↓

Similar Companies

TAHO PHARMACEUTICALS LTD.

1. TAH4411 Ondansetron ODF
2. TAH3311 Apixaban Oral Film
3. TAH3341 Apixaban Oral Extend Release Film
4. TAH2211 Buprenorphine/Naloxone Sublingual Film
5. TAH2231 Naloxone Buccal Film
6. TAH9922 Atomoxetine Oral Liquid
7. TAH9901 Methylphenidate Patch

AMARAN BIOTECHNOLOGY, INC.

1. Adjuvants
2. Drug Substance Manufacturing
3. Drug Product Manufacturing
4. Stability Study & Analytical Science Services
5. Sourcing & Consultation Services

BIONET Therapeutics Corp.

At BIONET Therapeutics Corp., our focus is on regenerative medicinal products, Advanced tech-enabled research and development, exosomes, and gene/cell therapy.